Market News & Trends
Catalent Increases Stake in Redwood Bioscience
Catalent Pharma Solutions recently announced that based on compelling data generated by the SMARTag ADC platform, it has increased its minority investment in Redwood Bioscience.…
Latest Frost Reports: Next-Generation Therapeutics for Infectious Diseases; Orphan Drugs Market
Next-Generation Therapeutics The available antivirals for commonly occurring infections, such as respiratory syncytial virus (RSV) and influenza are characterized by variable response, poor tolerability, and…
Pfanstiehl Launches cGMP-Produced, Non-Animal-Derived Galactose for Optimizing Cell Culture Media
Pfanstiehl recently announced the launch of its new high purity, low endotoxin, non-animal-derived Galactose (USP/NF, EP), manufactured in the US under strict cGMP, ICH Q7…
Overcoming Hurdles of HCMV Vaccine Development
Infections by Human Cytomegalovirus (HCMV) are among the medically most significant herpesvirus infections. About 30,000 to 40,000 infants p.a. are born already infected in the…
Gem Pharmaceuticals Announces $4.5-Million Financing for Phase II Trial
Gem Pharmaceuticals recently announced that current Gem board members/investors Diane Hendricks and Karl Leo have agreed to provide up to $4.5 million in new capital…
Rexam’s SOF’BAG: the Airless Package Now Available in 50 ml
Rexam Healthcare recently announced the latest version of its industry reference in airless package – the 50-ml Sof’Bag – in anticipation of the worldwide growth…
Global Migraine Market Value to Grow Modestly Despite Promising New Drugs
The global migraine treatment market value is expected to undergo a modest increase over the coming years, climbing from $2.5 billion in 2012 to $3.7…
Marina Biotech Continues to Build Worldwide Patent Protection for SMARTICLES
Marina Biotech, Inc. recently announced that a decision to grant a patent has been issued for the company's fundamental SMARTICLES delivery technology in Japan (Ser.…
Ensysce Biosciences Receives Patent for siRNA Delivery
Ensysce Biosciences Inc. recently announced the US Patent Office has issued a Notice of Allowance for US Patent Application No. 13/175,314: Single-Walled Carbon Nanotube/siRNA Complexes…
Eveon & Leti Advance Smart Bolus-Type Micro-Pump for Drug Delivery
Eveon and CEA-Leti recently announced the demonstration of liquid-pumping for smart drug delivery in the bolus mode using a silicon-based micro-pump fabricated with a standard…
Caisson Biotech Expands Drug Delivery Deal With Novo Nordisk
Caisson Biotech, LLC recently announced it has expanded the scope of its partnership with global healthcare leader Novo Nordisk A/S. This latest license agreement gives…
Gerresheimer Extends Medical Devices Operations in US
Gerresheimer AG, one of the world’s leading partners of the pharma and healthcare industry, is extending its production capacity for medical plastic systems at its…
Promethera Biosciences & EMD Millipore Join Forces
Promethera Biosciences recently announced a collaboration with EMD Millipore to develop an improved ready-to-use microfluidic perfusion liver assay. This new product is designed to perform…
Catalent Launches Advanced Technology for Glass-Free Delivery
Catalent Pharma Solutions recently announced it will launch its new ADVASEPT technology, for the advanced aseptic filling of injectable drugs, at the forthcoming INTERPHEX exhibition,…
Novozymes Biopharma Announces Major Collaboration With Janssen
Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has recently announced a collaboration with Janssen Research & Development, LLC (Janssen). The agreement…
Depomed Earns $10-Million Milestone
Depomed, Inc. recently announced that the US FDA approved Mallinckrodt plc's New Drug Application (NDA) for XARTEMIS XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII),…
Boom in Smart Pills Will Reach a New Peak by 2018-2020
The increasing need for convenient diagnostic and accurate therapeutic tools is driving innovation in smart pills. While certain smart pill applications, such as imaging and…
Corium International Files for IPO
Corium International, Inc., a commercial-stage biopharmaceutical company focused on the development, manufacture, and commercialization of specialty transdermal pharmaceutical products, recently announced it has filed a…
Catalent Announces Agreement Center for iPS Cell Research & Application
Catalent Pharma Solutions recently announced an agreement with the Center for iPS Cell Research and Application (CiRA) at Kyoto University in Japan to make a…
Curie-Cancer & DNA Therapeutics Partner in Fight Against Cancers
Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and DNA Therapeutics recently announced they are renewing their partnership. The ongoing collaboration will…
